Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD

Mourad, Jean‐Jacques; Cacoub, Patrice; Collet, Jean‐Philippe; Becker, F.; Pinel, J; Huet, D.; Sevestre‐Pietri, Marie‐Antoinette; Priollet, P.

doi:10.1016/j.jvs.2009.04.055

Cited by 55 publications

(35 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been demonstrated that the prevalence of ABI <0.9 is directly related to the patients age and to the stage of cardiac disease and ranges from 28% in subjects under 62 years to 52% in those over 81 years [16]. Our results are in agreement with those of Mourad et al [17] who studied a population of 2146 patients at high cardiovascular risk and found that 41% of them had ABI<0.9. Conversely, previous studies, which found lower PAD rates (30%), were performed in lower risk subjects such as patients hospitalized for nonvascular diseases or cardiovascular outpatients followed by general practitioners [10,18].…”

Section: Discussionsupporting

confidence: 92%

Lack of Benefits of Endurance Training in Patients with Chronic Heart Failure: Role of Asymptomatic Peripheral Artery Disease

Volterrani¹

2013

Int J Phys Med Rehabil

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 92%

Lack of Benefits of Endurance Training in Patients with Chronic Heart Failure: Role of Asymptomatic Peripheral Artery Disease

Volterrani¹

2013

Int J Phys Med Rehabil

View full text Add to dashboard Cite

“…1 Similar to previous reports, [2][3][4] this study concluded that the ABI can be used for PAD screening as well as to monitor the treatment of PAD. This editorial considers the pros and cons of screening for PAD.…”

supporting

confidence: 84%

Screening for Peripheral Arterial Disease Using the Ankle-Brachial Index in Diabetic and Other High-Risk Patients

2015

View full text Add to dashboard Cite

“…This suggests that the ABI measurement, for example, should be included in the evaluation of patients with CAD or CBVD to identify those with asymptomatic PAD, as indicated by previous studies. 21,22 Prevalence of a low ABI is elevated in asymptomatic patients with coronary (33.8%) or cerebrovascular (32.4%) disease, particularly if there are clinical manifestations in both territories (53.9%). 23 Moreover, a recent analysis of global REACH data showed that patients with PAD at baseline had twice the chance of progressing to polyvascular disease over 3 years than patients with CAD or CBVD.…”

Section: Discussionmentioning

confidence: 99%

Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry

Suárez

Zeymer²,

Limbourg

et al. 2010

Vasc Med

Self Cite

View full text Add to dashboard Cite

Cardiovascular event rates have been shown to increase substantially with the number of symptomatic disease locations. We sought to assess the risk profile, management and subsequent event rates of polyvascular disease patients. Consecutive outpatients were assessed for atherosclerotic risk factors and medications in the REACH Registry. A total of 19,117 symptomatic patients in Europe completed a 2-year follow-up: 77.2% with single arterial bed disease (coronary artery or cerebrovascular or peripheral arterial disease) and 22.8% with polyvascular disease (≥ 1 disease location). Polyvascular disease patients were older (68.5 ± 9.4 vs 66.3 ± 9.9 years, p < 0.0001), more often current or former smokers (64.9% vs 58.7%, p < 0.0001), and more often suffered from hypertension (59.5% vs 46.6%, p < 0.0001) and diabetes (34.5% vs 25.9%, p < 0.0001) than single arterial bed disease patients. Despite more intense medical therapy, risk factors (smoking, hypertension, low fasting glucose, and low fasting total cholesterol) were less often controlled in polyvascular disease patients. This was associated with substantially more events over 2 years compared with single arterial bed disease patients (cMACCE [cardiovascular death/non-fatal stroke/non-fatal MI] odds ratio, 1.63 [95% CI, 1.45—1.83], p < 0.0001). In conclusion, polyvascular disease patients have more cardiovascular risk factors, and the prognosis for these patients is significantly worse than for patients with single arterial bed disease. This suggests a need to improve detection and consequent medical treatment of polyvascular disease.

show abstract

Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD

Abstract: The high prevalence of asymptomatic PAD in this patient population suggests that ABI should systematically be performed in high-risk hospitalized patients to ensure that appropriate secondary prevention programs are initiated.

Cited by 55 publications

References 40 publications

Lack of Benefits of Endurance Training in Patients with Chronic Heart Failure: Role of Asymptomatic Peripheral Artery Disease

Lack of Benefits of Endurance Training in Patients with Chronic Heart Failure: Role of Asymptomatic Peripheral Artery Disease

Screening for Peripheral Arterial Disease Using the Ankle-Brachial Index in Diabetic and Other High-Risk Patients

Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry

Contact Info

Product

Resources

About